With the recent launches of Novo Nordisk’s Wegovy pill and Eli Lilly’s Foundayo, the obesity market has started to shift toward oral GLP-1 drugs. While Novo leverages its first-mover advantage with ...
Medscape UK : Get the latest medical news, drug alerts, expert commentary, clinical guidelines, and practice of medicine coverage for UK healthcare professionals.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果